Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Esperion Therapeutis.Inc. buy Needham & Company LLC

Start price
€2.40
25.03.24 / 50%
Target price
€7.38
25.03.25
Performance (%)
-26.19%
Price
€1.77
26.04.24
Summary
This prediction is currently active. The prediction for Esperion Therapeutis.Inc. disappoints with a performance of -26.19%. This prediction currently runs until 25.03.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this prediction

Esperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.

Performance without dividends (%)
Name 1w 1m
Esperion Therapeutis.Inc. -2.985% -2.985%
iShares Core DAX® 2.594% -1.861%
iShares Nasdaq 100 3.553% -2.064%
iShares Nikkei 225® 0.687% -8.704%
iShares S&P 500 2.209% -1.988%

Comments by Needham___Company_LL for this prediction

In the thread Esperion Therapeutis.Inc. diskutieren
Prediction Buy
Perf. (%) -26.19%
Target price 7.381
Change
Ends at 25.03.25

Esperion Therapeutics, Inc. (NASDAQ: ESPR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.
Ratings data for ESPR provided by MarketBeat

Stopped prediction by Needham___Company_LL for Esperion Therapeutis.Inc.

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.48
10.04.24
€7.42
10.04.25
-28.60%
26.04.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.67
27.02.24
€7.38
27.02.25
-33.65%
26.04.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€0.96
07.11.23
€7.48
07.11.24
84.72%
26.04.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€0.94
02.10.23
€8.55
02.10.24
87.66%
26.04.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.55
02.08.23
€8.23
02.08.24
14.14%
26.04.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.64
29.03.23
€11.06
29.03.24
69.95%
30.03.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.83
06.03.23
€15.01
06.03.24
-52.04%
07.03.24